Literature DB >> 18197701

Effects of metal-binding loop mutations on ligand binding to calcium- and integrin-binding protein 1. Evolution of the EF-hand?

Aaron P Yamniuk1, Jessica L Gifford, Sara Linse, Hans J Vogel.   

Abstract

Calcium- and integrin-binding protein 1 (CIB1) is a ubiquitous, multifunctional regulatory protein consisting of four helix-loop-helix EF-hand motifs. Neither EF-I nor EF-II binds divalent metal ions; however, EF-III is a mixed Mg2+/Ca2+-binding site, and EF-IV is a higher-affinity Ca2+-specific site. Through the generation of several CIB1 mutant proteins, we have investigated the importance of the last (-Z) metal-coordinating position of EF-III (D127) and EF-IV (E172) with respect to the binding of CIB1 to Mg2+, Ca2+, and its biological target, the cytoplasmic domain of the platelet alphaIIb integrin. A D127N mutant had reduced Mg2+ and Ca2+ affinity at EF-III but retained affinity for the alphaIIb domain. A D127E mutant had increased Mg2+ and Ca2+ affinity at EF-III, but unexpectedly, the affinity for the alphaIIb domain was too low for binding to be observed. E172Q and E172D mutants showed no and weak Mg2+ binding at EF-IV, respectively, and each mutant had reduced Ca2+ affinity at EF-IV and showed moderate metal-dependent differences in affinity for the alphaIIb domain. Finally, a D127Q mutant bound Mg2+ and Ca2+ in a manner similar to that of D127N, but like that of D127E, the affinity for the alphaIIb domain was reduced below the detection limit. These data, combined with a NMR-based structural comparison of the Mg2+- and Ca2+-loaded CIB1-alphaIIb peptide complexes, suggest that the D127E and D127Q mutations have a disruptive effect on alphaIIb binding since they expand the metal-binding loop and change the alpha-helix positions in EF-III. Conversely, upon replacement of the ancestral Glu with Asp at the -Z position of EF-III, CIB1 gained affinity for alphaIIb, and the Ca2+ affinity of CIB1 shifted into a range where the protein is able to act as an intracellular Ca2+ sensor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18197701     DOI: 10.1021/bi701494m

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

Review 1.  Calmodulin-related proteins step out from the shadow of their namesake.

Authors:  Kyle W Bender; Wayne A Snedden
Journal:  Plant Physiol       Date:  2013-08-01       Impact factor: 8.340

2.  Identification of novel integrin binding partners for calcium and integrin binding protein 1 (CIB1): structural and thermodynamic basis of CIB1 promiscuity.

Authors:  Thomas C Freeman; Justin L Black; Holly G Bray; Onur Dagliyan; Yi I Wu; Ashutosh Tripathy; Nikolay V Dokholyan; Tina M Leisner; Leslie V Parise
Journal:  Biochemistry       Date:  2013-09-25       Impact factor: 3.162

3.  Solution structures of Ca2+-CIB1 and Mg2+-CIB1 and their interactions with the platelet integrin alphaIIb cytoplasmic domain.

Authors:  Hao Huang; Hiroaki Ishida; Aaron P Yamniuk; Hans J Vogel
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

4.  Auxiliary Ca2+ binding sites can influence the structure of CIB1.

Authors:  Aaron P Yamniuk; Kathryn L Anderson; Marie E Fraser; Hans J Vogel
Journal:  Protein Sci       Date:  2009-05       Impact factor: 6.725

Review 5.  CIB1: a small protein with big ambitions.

Authors:  Tina M Leisner; Thomas C Freeman; Justin L Black; Leslie V Parise
Journal:  FASEB J       Date:  2016-04-26       Impact factor: 5.191

6.  Structural basis for the activation of platelet integrin αIIbβ3 by calcium- and integrin-binding protein 1.

Authors:  Hao Huang; Hans J Vogel
Journal:  J Am Chem Soc       Date:  2012-02-16       Impact factor: 15.419

7.  Preferential Binding of Mg2+ Over Ca2+ to CIB2 Triggers an Allosteric Switch Impaired in Usher Syndrome Type 1J.

Authors:  Rosario Vallone; Giuditta Dal Cortivo; Mariapina D'Onofrio; Daniele Dell'Orco
Journal:  Front Mol Neurosci       Date:  2018-08-17       Impact factor: 5.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.